D-0599-2024 Class III Ongoing
FDA drug recall D-0599-2024 was initiated by Rising Pharma Holding, Inc. on Jun 24, 2024 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit. The recall status is ongoing. Affected quantity: 868 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 17, 2024
- Initiation Date
- Jun 24, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 868 tubes
Product description
Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising Pharmaceuticals, Inc., East Brunswick, NJ 08816 NDC 64980-124-60
Reason for recall
Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.
Distribution pattern
Nationwide in the USA
Code information
Lot #, DI2303B, Exp 12/31/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0599-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026